MetaCap

Who Owns NewAmsterdam Pharma N.V. Stock?

NASDAQ: NAMSHealth CareBiotechnology: Pharmaceutical PreparationsUSD

18.41-1.10 (-5.64%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Ownership breakdown

Held by institutions
111.33%
Institutional holders
279
  • Institutions 99.1%
  • Insiders 0.9%
  • Public and other 0.0%

Who owns NewAmsterdam Pharma N.V. stock?

Institutional investors own about 111.3% of NewAmsterdam Pharma N.V.'s shares, spread across 279 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 0.89% of NAMS.

The largest institutional holders are Frazier Life Sciences Management, L.P. (15.83%), Capital World Investors (10.74%) and FMR, LLC (10.10%). Together, the top 10 institutions control 71.8% of shares outstanding. In their latest filings, 6 of the top 10 institutions increased their NAMS positions and 1 reduced them.

Summary generated from market data by MetaCap's automated system. Methodology

Top institutional holders of NAMS

NewAmsterdam Pharma N.V. top institutional holders
InstitutionShares% HeldChange
Frazier Life Sciences Management, L.P. 18.99M15.83%+5.0%
Capital World Investors12.88M10.74%+5.3%
FMR, LLC12.12M10.10%+17.2%
RA Capital Management, L.P.9.55M7.96%0.0%
Janus Henderson Group Ltd.8.97M7.48%+297.2%
FCPM III Services B.V.8.49M7.08%0.0%
Deerfield Management Company, L.P4.25M3.55%-0.3%
Bain Capital Life Sciences Investors, LLC3.81M3.17%0.0%
Orbis Allan Gray Ltd3.76M3.14%+115.2%
Duquesne Family Office Llc3.36M2.80%+9.3%

% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.

Top mutual fund and ETF holders of NAMS

NewAmsterdam Pharma N.V. top fund holders
FundShares% Held
SmallCap World Fund Inc9.56M7.97%
Fidelity Contrafund2.30M1.92%
Fidelity Rutland Square TRT II-Strategic Advisers Fidelity U.S. Total 2.20M1.84%
New Economy Fund1.25M1.04%
JANUS INVESTMENT FUND-Janus Henderson Global Life Sciences Fund1.16M0.97%
Fidelity Select Portfolios-Select Health Care Portfolio1.02M0.85%
T. Rowe Price Health Sciences Fund, Inc.912.50K0.76%
Capital Group Eqy. ETF TRT I-Capital Group U.S. Small and Mid Cap ETF705.50K0.59%
American Century Mutual Funds, Inc.-Small Cap Growth Fund655.54K0.55%
Fidelity Advisor Series VII-Fidelity Advisor Biotechnology Fund618.10K0.52%

Frequently asked questions

Who is the largest shareholder of NewAmsterdam Pharma N.V.?

Frazier Life Sciences Management, L.P. is the largest institutional shareholder of NAMS, owning 15.83% of shares outstanding (18.99M shares) as of its latest 13F filing.

What percentage of NewAmsterdam Pharma N.V. is owned by institutions?

Institutions own about 111.3% of NAMS shares and 112.3% of the public float.

How much of NewAmsterdam Pharma N.V. do insiders own?

Insiders, such as officers and directors, own about 0.89% of NAMS shares outstanding.

Where does institutional ownership data come from?

Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.

Related